KEY FEATURES
| Full Name | Chemokine C-X-C-Motif Receptor 6 |
|---|---|
| Synonym | CD186; BONZO; STRL33; TYMSTR; G-protein coupled receptor STRL33; G-protein coupled receptor bonzo |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.15-10ng/mL |
| Sensitivity | 0.06ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human CXCR6 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human CXCR6. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human CXCR6 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human CXCR6, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human CXCR6. You can calculate the concentration of Human CXCR6 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human CXCR6 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.55 | 0.89 | 4.75 | 0.51 | 0.97 | 4.28 |
| Standard deviation | 0.03 | 0.05 | 0.15 | 0.03 | 0.05 | 0.23 |
| CV(%) | 5.89 | 5.74 | 3.26 | 6.66 | 5.65 | 5.48 |
RECOVERY
The recovery of Human CXCR6 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 88-98 | 93 |
| EDTA plasma (n=8) | 96-110 | 101 |
| Cell culture media (n=8) | 84-100 | 91 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human CXCR6 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with CXCR6 ELISA Kits
| CXCL16 ELISA Kit | publications with CXCR6 and CXCL16 |
| CCR5 ELISA Kit | publications with CXCR6 and CCR5 |
| CXCL10 ELISA Kit | publications with CXCR6 and CXCL10 |
| CCL5 ELISA Kit | publications with CXCR6 and CCL5 |
| CCL20 ELISA Kit | publications with CXCR6 and CCL20 |
| CXCL9 ELISA Kit | publications with CXCR6 and CXCL9 |
| CXCL13 ELISA Kit | publications with CXCR6 and CXCL13 |
| CCL21 ELISA Kit | publications with CXCR6 and CCL21 |
| CCL19 ELISA Kit | publications with CXCR6 and CCL19 |
| CXCL11 ELISA Kit | publications with CXCR6 and CXCL11 |
Pathways associated with CXCR6 ELISA Kit
| Chemokine Receptors Bind Chemokines Pathway | Chemokine Receptors Bind Chemokines Pathway |
| Chemokine Signaling Pathway | Chemokine Signaling Pathway |
| Class A/1 (Rhodopsin-like Receptors) Pathway | Class A/1 (Rhodopsin-like Receptors) Pathway |
| Cytokine-cytokine Receptor Interaction Pathway | Cytokine-cytokine Receptor Interaction Pathway |
| Defective ACTH Causes Obesity And Pro-opiomelanocortinin Deficiency (POMCD) Pathway | Defective ACTH Causes Obesity And Pro-opiomelanocortinin Deficiency (POMCD) Pathway |
| Disease Pathway | Disease Pathway |
| G Alpha (i) Signalling Events Pathway | G Alpha (i) Signalling Events Pathway |
| GPCR Downstream Signaling Pathway | GPCR Downstream Signaling Pathway |
Diseases associated with CXCR6 ELISA Kit
| Lung Diseases | publications with CXCR6 and Lung Diseases |
| Nervous System Diseases | publications with CXCR6 and Nervous System Diseases |
| Skin Diseases | publications with CXCR6 and Skin Diseases |
| Brain Diseases | publications with CXCR6 and Brain Diseases |
| Liver Neoplasms | publications with CXCR6 and Liver Neoplasms |
| Breast Neoplasms | publications with CXCR6 and Breast Neoplasms |
| Neoplasms, Experimental | publications with CXCR6 and Neoplasms, Experimental |
| Demyelinating Diseases | publications with CXCR6 and Demyelinating Diseases |
| Lymphoma | publications with CXCR6 and Lymphoma |
| Carcinoma, Hepatocellular | publications with CXCR6 and Carcinoma, Hepatocellular |
Organs/Tissues associated with CXCR6 ELISA Kit
| Brain | publications with CXCR6 and Brain |
| Kidney | publications with CXCR6 and Kidney |
| Spleen | publications with CXCR6 and Spleen |
| Placenta | publications with CXCR6 and Placenta |
| Uterus | publications with CXCR6 and Uterus |
| Mammary Gland | publications with CXCR6 and Mammary Gland |